Cardiovascular Involvement in Fabry's Disease : New Advances in Diagnostic Strategies, Outcome Prediction and Management
Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd..
Cardiovascular involvement is common in Fabry's disease and is the leading cause of morbidity and mortality. The research is focused on identifying diagnostic clues suggestive of cardiovascular involvement in the preclinical stage of the disease through clinical and imaging markers. Different pathophysiologically driven therapies are currently or will soon be available for the treatment of Fabry's disease, with the most significant benefit observed in the early stages of the disease. Thus, early diagnosis and risk stratification for adverse outcomes are crucial to determine when to start an aetiological treatment. This review describes the cardiovascular involvement in Fabry's disease, focusing on the advances in diagnostic strategies, outcome prediction and disease management.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
|---|---|
| Enthalten in: |
Cardiac failure review - 9(2023) vom: 09., Seite e12 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Monda, Emanuele [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Diagnosis |
|---|
| Anmerkungen: |
Date Revised 23.08.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.15420/cfr.2023.06 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM361008872 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM361008872 | ||
| 003 | DE-627 | ||
| 005 | 20231226084233.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.15420/cfr.2023.06 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1203.xml |
| 035 | |a (DE-627)NLM361008872 | ||
| 035 | |a (NLM)37602190 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Monda, Emanuele |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular Involvement in Fabry's Disease |b New Advances in Diagnostic Strategies, Outcome Prediction and Management |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.08.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © The Author(s), 2023. Published by Radcliffe Group Ltd. | ||
| 520 | |a Cardiovascular involvement is common in Fabry's disease and is the leading cause of morbidity and mortality. The research is focused on identifying diagnostic clues suggestive of cardiovascular involvement in the preclinical stage of the disease through clinical and imaging markers. Different pathophysiologically driven therapies are currently or will soon be available for the treatment of Fabry's disease, with the most significant benefit observed in the early stages of the disease. Thus, early diagnosis and risk stratification for adverse outcomes are crucial to determine when to start an aetiological treatment. This review describes the cardiovascular involvement in Fabry's disease, focusing on the advances in diagnostic strategies, outcome prediction and disease management | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Fabry’s disease | |
| 650 | 4 | |a diagnosis | |
| 650 | 4 | |a hypertrophic cardiomyopathy | |
| 650 | 4 | |a management | |
| 650 | 4 | |a outcome | |
| 700 | 1 | |a Falco, Luigi |e verfasserin |4 aut | |
| 700 | 1 | |a Palmiero, Giuseppe |e verfasserin |4 aut | |
| 700 | 1 | |a Rubino, Marta |e verfasserin |4 aut | |
| 700 | 1 | |a Perna, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Diana, Gaetano |e verfasserin |4 aut | |
| 700 | 1 | |a Verrillo, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Dongiglio, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Cirillo, Annapaola |e verfasserin |4 aut | |
| 700 | 1 | |a Fusco, Adelaide |e verfasserin |4 aut | |
| 700 | 1 | |a Caiazza, Martina |e verfasserin |4 aut | |
| 700 | 1 | |a Limongelli, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cardiac failure review |d 2015 |g 9(2023) vom: 09., Seite e12 |w (DE-627)NLM27459143X |x 2057-7540 |7 nnns |
| 773 | 1 | 8 | |g volume:9 |g year:2023 |g day:09 |g pages:e12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.15420/cfr.2023.06 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 9 |j 2023 |b 09 |h e12 | ||